News Embryonic Stem Cells Improve Vision, Appear Safe at 22 Months by Medscape • 2014/10/15 • 0 Comments Phase 1/2 studies conducted in the United States are the first to report the long-term safety and possible biological activity of human embryonic stem cell transplants in human disease. Medscape Medical News Full Story →